This suggests that the therapeutic properties of RV occur in a dose-dependent manner, so the aim of this study was to evaluate the effect of the oral administration of RV at a dose of 500 mg/day compared with 1000 mg/day on markers of SIRT1 and SIRT1 in older adults with T2D. This evidence concerns the gene SIRT1 and type 2 diabetes mellitus.